Science ❯ Medical Research

Drug Development

Clinical Trials Clinical Research Immunotherapy Antibody-Drug Conjugates Sickle Cell Treatment Genetics FDA Approval Investigational Drugs Innovation RNA Splicing Therapeutic Approaches Therapeutic Uses Parkinson's Disease Clinical Studies Tirzepatide Preclinical Trials Pediatric Treatments Clinical Guidelines Complex Generics Delivery Systems Clinical Applications Efficacy Studies Cancer Treatments Therapeutics Oncology FDA Approvals Vaccines

FDA Approves First Broad RAS Inhibitor for Metastatic Pancreatic Cancer

The decision opens the first effective targeted option against KRAS-driven pancreatic tumors, raising urgent questions about pricing, payer access, and the drug’s commercial rollout.

Novartis to Acquire Myricx Bio for Up to $1.5 Billion

Axsome Reports 57% Q1 Sales Jump as FDA Clears Auvelity for Alzheimer’s Agitation

Eli Lilly’s GLP-1 Lead Faces New Pressure From Novo’s Weight-Loss Pill

Mira Pharmaceuticals Soars After Oral Pain Drug Outperforms Morphine in Preclinical Test

Tubulis Raises €308 Million Series C to Accelerate Lead Cancer ADC